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Metastatic hepatocellular carcinoma in brain masquerading as rhabdoid CNS tumor -A case report
Editor, Meningiomas are notorious for the variety of their cytological and histological presentations. These tumors are further segregated into three grades based on mitosis, cellularity, brain invasion, and presence of necrosis. The variants of high-grade meningiomas include the following: anaplastic, chordoid, and rhabdoid types. Rhabdoid meningioma has got a very aggressive course and poor prognosis for the patient. However, it is essential to differentiate this variant morphologically from other rhabdoid morphology tumors of central nervous system (CNS) as they have an entirely different management. The incidence of hepatocellular carcinoma (HCC) metastasizing to brain is extremely rare, occurring in ~1% of HCC patients. [1] We report a case of 60-year-old male presenting with an occipital swelling with an initial diagnosis of sebaceous cyst scalp in a primary health center. During operation of the swelling, he started bleeding profusely and was rushed to our tertiary care center for emergency surgery. The dural mass measuring 7 × 4-cm bled easily on touch. Since the patient was wheeled in as an emergency, no preoperative MRI/CT-scan was available. Microscopy revealed an uncapsulated tumor infiltrating into the overlying bony tissue. Tumor displayed sheets of loosely cohesive atypical cells in vague trabecular and nodular pattern. Tumor cells had rhabdoid morphology, having a large size, abundant dense eosinophilic cytoplasm, round, eccentric pleomorphic nuclei with vesicular chromatin and prominent nucleoli. Tumor cells also showed prominent hyaline, paranuclear, intracytoplasmic inclusions, and brisk mitotic activity [ Figure 1a ]. No necrosis, glomeruloid proliferation, or psammoma bodies were seen. The tumor was seen invading the overlying bony trabeculae and the underlying brain tissue. A differential diagnosis of rhabdoid meningioma, atypical teratoid/rhabdoid teratoma (ATRT), malignant melanoma, and metastases was entertained. Immunohistochemistry (IHC) of tissue revealed tumor cells to be positive for Pan CK [ Figure 1b ], CK20, and focal positivity for EMA was noticed. Tumor cells were negative for vimentin (ruling out meningioma) [ Figure 1c ] and HMB45 (ruling out melanoma). S100, LCA, GFAP, and CD34 IHC were also reported negative. There was no loss of INI-1 protein expression (ruling out ATRT) [ Figure 1d ], and MiB labeling index was 10%. At this stage a metastatic tumor with unknown primary was entertained. To narrow down the primary site following IHC were performed -CDX2, TTF1, calretenin, and NSE. However all of them were reported negative thereby ruling out metastasis from gastrointestinal tract, lung, thyroid, adrenal, and kidney. The full body PET scan and CT scan showed small space occupying lesion in liver with multiple mediastinal and retroperitoneal enlarged lymph nodes [ Figure 1e and f]. Serum AFP was not raised. Subsequently, Hep Par-1 IHC of brain metastasis was carried out in a different referral center that revealed tumor cells to be positive [ Figure 1g ]. At our center, a liver biopsy was carried out, which showed a well-differentiated HCC [ Figure 1h ].
Dural CNS metastases are often from breast and prostate, but also unusual primaries such as HCC have been described in intradural sites. [2] Approximately 25% (range: 14%-37%) of patients with HCC develop extrahepatic metastasis. The most common sites of this type of metastasis are in lymph nodes and the lungs. Occasionally, bones, adrenal glands, and brain may also be seeded. [3] Brain involvement by HCC is extremely rare. Only close to 60 cases have been reported in literature till date. The overall survival and 5-year survival rates of HCC patients with brain metastases are 2.7% and 5%, respectively. [4] Rhabdoid meningioma has been found to be histologically indistinguishable from other CNS tumors having rhabdoid morphology. [5] Rhabdoid meningiomas are rare, aggressive variant of meningiomas, which may be evident on initial presentation or appear only in recurrent tumors.
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Synchronous malignancies: A tale of two different tumors
Editor, Synchronous tumors refer to occurrence of a second malignancy in a patient with a known primary. While synchronous lesions occur within 6 months of diagnosis of a previous neoplasm, metachronus tumors occur >6 months apart. [1] While nationwide frequency of thyroid cancer in Indian population has been reported to be only 0.1%-0.2% of all cancers, [2] breast cancer is now the most common cancer in Indian females in most cities and is on a rising trend. [3] A 55-year-old postmenopausal female presented with 3 × 3 cm right breast lump for 10 months. Radiological findings were suggestive of BIRADS IV lesion [ Figure 1a ]. General patient examination revealed another diffuse midline neck bulge measuring approximately 3 × 3 cm, moving with deglutition. The patient had not suspected a neck swelling otherwise. A contrast enhanced computed tomography of neck, chest, and abdomen was done, which revealed discrete lesions in breast and thyroid [ Figure 1b Figure 3a -g] showed highly cellular smears with follicular epithelial cells arranged in large papillary fragments and sheets. Considerable nuclear overlapping and overcrowding with characteristic intranuclear grooves and inclusions were noted. Background showed thick and thin colloid with scattered hurthle cells. Thus, confirming diagnosis of papillary carcinoma thyroid (Bethesda Category 6). Pre-op molecular testing for BRAF (V600E) was not done as the cytomorphology was diagnostic. Our patient underwent trucut biopsy from the breast lesion and a total thyroidectomy. Features were suggestive of Infiltrating duct carcinoma, no special type [ Figure 2g and h]. Molecular subtype was basal like; triple negative for ER, PR, and Her-2neu [ Figure 2i ]. The
